Metabolic reprogramming in endometriosis: mechanisms and therapeutic prospects

Cuishan Guo, Guo C, Xinni Na, Na X, Guo Z, Zechen Guo, Jiao J, Jiao Jiao, Yang M, Mengyi Yang, Junzhi Liang, Liang J, Dai W, Wanlin Dai, Zhijing Na, Na Z, Zhongxiu Jiang, Jiang Z, Yan Li, Li Y, Li D, Da Li
Journal of advanced research · 2026 · doi:10.1016/j.jare.2026.04.069 · PMID:42086184 · W7160415639
review OA: gold public-domain-us
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This review details how metabolic reprogramming in endometriosis, marked by altered glycolysis, fatty acid oxidation, and amino acid metabolism, drives lesion progression and infertility, and assesses therapeutic targeting of these pathways.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Endometriosis (EMS) is an estrogen-dependent chronic inflammatory disorder for which metabolic reprogramming has emerged as a central pathological feature. Driven by genetic, epigenetic, and microenvironmental stressors, ectopic endometrial cells undergo extensive metabolic remodeling integrating energy production, redox homeostasis, and biosynthetic demands. These adaptations not only sustain cell survival under hypoxia and inflammation, but reshape epigenetic marks and the immune microenvironment, promoting lesion progression and impairing reproductive function. AIM OF REVIEW: This review systematically outlines the molecular mechanisms of metabolic reprogramming in EMS, examines its impact on lesion development and fertility, and evaluates the potential of targeting metabolic pathways for precision therapy. KEY SCIENTIFIC CONCEPTS: Ectopic endometrial cells display a phenotype with enhanced aerobic glycolysis, dysregulated fatty acid oxidation and phospholipid synthesis, and abnormal amino acid metabolism. These alterations support lesion survival and proliferation through epigenetic and immune modulation. Granulosa cell metabolic reprogramming-characterized by excessive glycolysis, mitochondrial dysfunction, lipid accumulation, and iron overload-disrupts oocyte energy and redox balance, reducing oocyte quality, and contributing to EMS-associated infertility. Preclinical studies suggest that targeting glucose, lipid, and amino acid pathways could mitigate disease phenotypes; however, metabolic plasticity, overlap with physiological metabolism, and safety concerns limit clinical translation. These challenges highlight the need for combinatorial interventions, precise delivery, and optimized therapeutic strategies to improve patient outcomes.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (1)

SciLite annotations

chemicals 9
estrogen fatty acid phospholipid amino acid lipid iron glucose lipid amino acid

Source provenance

europepmc
last seen: 2026-07-29T06:27:48.050232+00:00
openalex
last seen: 2026-07-29T06:19:52.536310+00:00
pubmed
last seen: 2026-07-29T06:22:14.364230+00:00
scilite
last seen: 2026-07-26T09:53:43.985191+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine